Inventor · disambiguated record
Walter F. Lima
Also filed as: LIMA WALTER · LIMA WALTER F
17 granted patents·19 pending applications·663 citations·filing 1992–2021
95Inventor score
Files withISIS PHARMACEUTICALS INC15IONIS PHARMACEUTICALS INC5LIMA WALTER F2MANOHARAN MUTHIAH2MIGAWA MICHAEL T1
Top patents by PatentIndex Score
36 records- 0194US9738895B2Oligomeric compounds and methodsIONIS PHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·10 cites·21 claims
- 0294US8987435B2Oligomeric compounds and methodsSWAYZE ERIC E·Filed 2009·Granted Mar 24, 2015·20 cites·23 claims
- 0394US5686242ADetermination of oligonucleotides for therapeutics, diagnostics and research reagentsISIS PHARMACEUTICALS INC·Filed 1994·Granted Nov 11, 1997·157 cites·77 claims
- 0491US6617442B1Human Rnase H1 and oligonucleotide compositions thereofISIS PHARMACEUTICALS INC·Filed 1999·Granted Sep 9, 2003·122 cites·7 claims
- 0590US11104899B2Oligomer-conjugate complexes and their useIONIS PHARMACEUTICALS INC·Filed 2018·Granted Aug 31, 2021·3 cites·20 claims
- 0690US6423489B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1995·Granted Jul 23, 2002·120 cites·7 claims
- 0788US9725479B25′-end derivativesMANOHARAN MUTHIAH·Filed 2011·Granted Aug 8, 2017·12 cites·15 claims
- 0887US10023861B2Oligomer-conjugate complexes and their usePRAKASH THAZHA P·Filed 2012·Granted Jul 17, 2018·9 cites·21 claims
- 0984US8790919B2Compositions and methods for optimizing cleavage of RNA by RNase HMIGAWA MICHAEL T·Filed 2005·Granted Jul 29, 2014·9 cites·21 claims
- 1083US6391542B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1996·Granted May 21, 2002·95 cites·8 claims
- 1180US5582972AAntisense oligonucleotides to the RAS geneISIS PHARMACEUTICALS INC·Filed 1992·Granted Dec 10, 1996·57 cites·5 claims
- 1278US6376661B1Human RNase H and compositions and uses thereofISIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 23, 2002·3 cites·1 claims
- 1373US6001653AHuman type 2 RNase HISIS PHARMACEUTICALS INC·Filed 1998·Granted Dec 14, 1999·20 cites·17 claims
- 1471US2022025370A1Oligomer-conjugate complexes and their useIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1569US6855530B2Human RNase H1 mutantsISIS PHARMACEUTICALS INC·Filed 2001·Granted Feb 15, 2005·1 cites·5 claims
- 1666US6022691ADetermination of oligonucleotides for therapeutics, diagnostics and research reagentsISIS PHARMACEUTICALS INC·Filed 1997·Granted Feb 8, 2000·25 cites·7 claims
- 1766US2020270609A1Single-Stranded RNAI Oligonucleotides Targeting APOC-IIIIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1861US8093061B2Methods of determining potency of chemically-synthesized oligonucleotidesLIMA WALTER F·Filed 2007·Granted Jan 10, 2012·0 cites·39 claims
- 1961US2005153340A1Human RNase H and compositions and uses thereofFiled 2004·Application pending·0 cites
- 2061US2004102618A1Human RNase H1 and oligonucleotide compositions thereofISIS PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2161US2005153921A1Methods of using mammalian RNase H and compositions thereofFiled 2004·Application pending·0 cites
- 2259US2013252243A1Methods of determining potency of chemically-synthesized oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2359US2007292875A1Human RNase H1 oligonucleotide compositions thereofISIS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2458US2016122761A1Compositions and methods for modulation of target nucleic acidsISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2557US2019127737A1Single-stranded rnai oligonucleotides targeting apoc-iiiIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2657US2002110892A1Human RNase H and compositions and uses thereofFiled 2001·Application pending·0 cites
- 2756US8338185B2Methods of determining potency of chemically-synthesized oligonucleotidesLIMA WALTER F·Filed 2011·Granted Dec 25, 2012·0 cites·13 claims
- 2856US2002076712A1Human RNase H and compositions and uses thereofFiled 2001·Application pending·0 cites
- 2951US2015011001A1Compositions and methods for optimizing cleavage of rna by rnase hISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3051US2001044145A1Methods of using mammalian RNase H and compositions thereofFiled 2001·Application pending·0 cites
- 3151US2004248145A1Methods of using mammalian RNase H and compositions thereofFiled 2003·Application pending·0 cites
- 3251US2010093836A1Compounds and methods for modulating protein expressionISIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3351US2003144496A1Human RNase H and compositions and uses thereofFiled 2003·Application pending·0 cites
- 3450US2004180433A1Methods of using mammalian RNase H and compositions thereofFiled 2001·Application pending·0 cites
- 3547US2005164234A1Methods of using mammalian RNase H and compositions thereofFiled 2004·Application pending·0 cites
- 3642US2013156845A1Lipid formulated single stranded rnaMANOHARAN MUTHIAH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Walter F. Lima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →